nodes	percent_of_prediction	percent_of_DWPC	metapath
Mepivacaine—Laryngeal oedema—Lisinopril—systemic scleroderma	0.012	0.012	CcSEcCtD
Mepivacaine—Swelling—Pentoxifylline—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Mepivacaine—Meningitis—Prednisone—systemic scleroderma	0.0118	0.0118	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Pentoxifylline—systemic scleroderma	0.0108	0.0108	CcSEcCtD
Mepivacaine—Apnoea—Mycophenolic acid—systemic scleroderma	0.0101	0.0101	CcSEcCtD
Mepivacaine—Urinary incontinence—Mycophenolic acid—systemic scleroderma	0.00826	0.00826	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Captopril—systemic scleroderma	0.00816	0.00816	CcSEcCtD
Mepivacaine—Drowsiness—Pentoxifylline—systemic scleroderma	0.00803	0.00803	CcSEcCtD
Mepivacaine—Apnoea—Mycophenolate mofetil—systemic scleroderma	0.00797	0.00797	CcSEcCtD
Mepivacaine—Sweating—Pentoxifylline—systemic scleroderma	0.0077	0.0077	CcSEcCtD
Mepivacaine—Cardiac arrest—Captopril—systemic scleroderma	0.00751	0.00751	CcSEcCtD
Mepivacaine—Swelling—Mycophenolic acid—systemic scleroderma	0.00704	0.00704	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Leflunomide—systemic scleroderma	0.00673	0.00673	CcSEcCtD
Mepivacaine—Urinary incontinence—Mycophenolate mofetil—systemic scleroderma	0.00652	0.00652	CcSEcCtD
Mepivacaine—Erythema—Pentoxifylline—systemic scleroderma	0.00628	0.00628	CcSEcCtD
Mepivacaine—Tension—Pentoxifylline—systemic scleroderma	0.00616	0.00616	CcSEcCtD
Mepivacaine—Nervousness—Pentoxifylline—systemic scleroderma	0.0061	0.0061	CcSEcCtD
Mepivacaine—Back pain—Pentoxifylline—systemic scleroderma	0.00607	0.00607	CcSEcCtD
Mepivacaine—Vision blurred—Pentoxifylline—systemic scleroderma	0.00592	0.00592	CcSEcCtD
Mepivacaine—Cardiac arrest—Mycophenolic acid—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Mepivacaine—Urinary retention—Mycophenolic acid—systemic scleroderma	0.00591	0.00591	CcSEcCtD
Mepivacaine—Tremor—Pentoxifylline—systemic scleroderma	0.00588	0.00588	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Lisinopril—systemic scleroderma	0.00578	0.00578	CcSEcCtD
Mepivacaine—Agitation—Pentoxifylline—systemic scleroderma	0.00577	0.00577	CcSEcCtD
Mepivacaine—Angioedema—Pentoxifylline—systemic scleroderma	0.00574	0.00574	CcSEcCtD
Mepivacaine—Paralysis—Methotrexate—systemic scleroderma	0.00551	0.00551	CcSEcCtD
Mepivacaine—Sweating increased—Leflunomide—systemic scleroderma	0.00548	0.00548	CcSEcCtD
Mepivacaine—Convulsion—Pentoxifylline—systemic scleroderma	0.00544	0.00544	CcSEcCtD
Mepivacaine—Hypertension—Pentoxifylline—systemic scleroderma	0.00542	0.00542	CcSEcCtD
Mepivacaine—Anxiety—Pentoxifylline—systemic scleroderma	0.00533	0.00533	CcSEcCtD
Mepivacaine—Cardiac arrest—Lisinopril—systemic scleroderma	0.00532	0.00532	CcSEcCtD
Mepivacaine—Back pain—Mometasone—systemic scleroderma	0.00524	0.00524	CcSEcCtD
Mepivacaine—Anaphylactic shock—Pentoxifylline—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Mepivacaine—Oedema—Pentoxifylline—systemic scleroderma	0.00512	0.00512	CcSEcCtD
Mepivacaine—Shock—Pentoxifylline—systemic scleroderma	0.00504	0.00504	CcSEcCtD
Mepivacaine—Tachycardia—Pentoxifylline—systemic scleroderma	0.005	0.005	CcSEcCtD
Mepivacaine—Hyperhidrosis—Pentoxifylline—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Mepivacaine—Angioedema—Mometasone—systemic scleroderma	0.00495	0.00495	CcSEcCtD
Mepivacaine—Hypotension—Pentoxifylline—systemic scleroderma	0.00479	0.00479	CcSEcCtD
Mepivacaine—Sweating increased—Lisinopril—systemic scleroderma	0.00471	0.00471	CcSEcCtD
Mepivacaine—Tension—Captopril—systemic scleroderma	0.00467	0.00467	CcSEcCtD
Mepivacaine—Urinary retention—Mycophenolate mofetil—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Mepivacaine—Cardiac arrest—Mycophenolate mofetil—systemic scleroderma	0.00466	0.00466	CcSEcCtD
Mepivacaine—Nervousness—Captopril—systemic scleroderma	0.00462	0.00462	CcSEcCtD
Mepivacaine—Sweating—Mycophenolic acid—systemic scleroderma	0.00459	0.00459	CcSEcCtD
Mepivacaine—Somnolence—Pentoxifylline—systemic scleroderma	0.00455	0.00455	CcSEcCtD
Mepivacaine—Apnoea—Methotrexate—systemic scleroderma	0.00451	0.00451	CcSEcCtD
Mepivacaine—Vision blurred—Captopril—systemic scleroderma	0.00448	0.00448	CcSEcCtD
Mepivacaine—Anaphylactic shock—Mometasone—systemic scleroderma	0.00442	0.00442	CcSEcCtD
Mepivacaine—Bradycardia—Mycophenolic acid—systemic scleroderma	0.00437	0.00437	CcSEcCtD
Mepivacaine—Angioedema—Captopril—systemic scleroderma	0.00435	0.00435	CcSEcCtD
Mepivacaine—Chills—Azathioprine—systemic scleroderma	0.00428	0.00428	CcSEcCtD
Mepivacaine—Syncope—Captopril—systemic scleroderma	0.00427	0.00427	CcSEcCtD
Mepivacaine—Loss of consciousness—Captopril—systemic scleroderma	0.00418	0.00418	CcSEcCtD
Mepivacaine—Sweating—Lisinopril—systemic scleroderma	0.00413	0.00413	CcSEcCtD
Mepivacaine—Urticaria—Pentoxifylline—systemic scleroderma	0.00407	0.00407	CcSEcCtD
Mepivacaine—Body temperature increased—Pentoxifylline—systemic scleroderma	0.00405	0.00405	CcSEcCtD
Mepivacaine—Chills—Leflunomide—systemic scleroderma	0.00404	0.00404	CcSEcCtD
Mepivacaine—Tinnitus—Mycophenolic acid—systemic scleroderma	0.00401	0.00401	CcSEcCtD
Mepivacaine—Paraesthesia—Mometasone—systemic scleroderma	0.00397	0.00397	CcSEcCtD
Mepivacaine—Bradycardia—Lisinopril—systemic scleroderma	0.00394	0.00394	CcSEcCtD
Mepivacaine—Anaphylactic shock—Captopril—systemic scleroderma	0.00388	0.00388	CcSEcCtD
Mepivacaine—Chills—Mycophenolic acid—systemic scleroderma	0.00386	0.00386	CcSEcCtD
Mepivacaine—Shock—Captopril—systemic scleroderma	0.00382	0.00382	CcSEcCtD
Mepivacaine—Back pain—Leflunomide—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Mepivacaine—Tachycardia—Captopril—systemic scleroderma	0.00379	0.00379	CcSEcCtD
Mepivacaine—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.00377	0.00377	CcSEcCtD
Mepivacaine—Vision blurred—Leflunomide—systemic scleroderma	0.0037	0.0037	CcSEcCtD
Mepivacaine—Asthenia—Pentoxifylline—systemic scleroderma	0.00368	0.00368	CcSEcCtD
Mepivacaine—Tension—Mycophenolic acid—systemic scleroderma	0.00367	0.00367	CcSEcCtD
Mepivacaine—Nervousness—Mycophenolic acid—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Mepivacaine—Hypotension—Captopril—systemic scleroderma	0.00363	0.00363	CcSEcCtD
Mepivacaine—Pruritus—Pentoxifylline—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Mepivacaine—Sweating—Mycophenolate mofetil—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Mepivacaine—Back pain—Mycophenolic acid—systemic scleroderma	0.00362	0.00362	CcSEcCtD
Mepivacaine—Tinnitus—Lisinopril—systemic scleroderma	0.00361	0.00361	CcSEcCtD
Mepivacaine—Angioedema—Leflunomide—systemic scleroderma	0.00358	0.00358	CcSEcCtD
Mepivacaine—Vision blurred—Mycophenolic acid—systemic scleroderma	0.00353	0.00353	CcSEcCtD
Mepivacaine—Tremor—Mycophenolic acid—systemic scleroderma	0.0035	0.0035	CcSEcCtD
Mepivacaine—Body temperature increased—Mometasone—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Mepivacaine—Paraesthesia—Captopril—systemic scleroderma	0.00349	0.00349	CcSEcCtD
Mepivacaine—Chills—Lisinopril—systemic scleroderma	0.00347	0.00347	CcSEcCtD
Mepivacaine—Bradycardia—Mycophenolate mofetil—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Mepivacaine—Somnolence—Captopril—systemic scleroderma	0.00345	0.00345	CcSEcCtD
Mepivacaine—Agitation—Mycophenolic acid—systemic scleroderma	0.00344	0.00344	CcSEcCtD
Mepivacaine—Dizziness—Pentoxifylline—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Mepivacaine—Hypertension—Leflunomide—systemic scleroderma	0.00339	0.00339	CcSEcCtD
Mepivacaine—Erythema—Lisinopril—systemic scleroderma	0.00337	0.00337	CcSEcCtD
Mepivacaine—Syncope—Mycophenolic acid—systemic scleroderma	0.00335	0.00335	CcSEcCtD
Mepivacaine—Anxiety—Leflunomide—systemic scleroderma	0.00333	0.00333	CcSEcCtD
Mepivacaine—Tension—Lisinopril—systemic scleroderma	0.00331	0.00331	CcSEcCtD
Mepivacaine—Loss of consciousness—Mycophenolic acid—systemic scleroderma	0.00329	0.00329	CcSEcCtD
Mepivacaine—Nervousness—Lisinopril—systemic scleroderma	0.00327	0.00327	CcSEcCtD
Mepivacaine—Back pain—Lisinopril—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Mepivacaine—Vomiting—Pentoxifylline—systemic scleroderma	0.00326	0.00326	CcSEcCtD
Mepivacaine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00324	0.00324	CcSEcCtD
Mepivacaine—Hypertension—Mycophenolic acid—systemic scleroderma	0.00323	0.00323	CcSEcCtD
Mepivacaine—Headache—Pentoxifylline—systemic scleroderma	0.00321	0.00321	CcSEcCtD
Mepivacaine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.0032	0.0032	CcSEcCtD
Mepivacaine—Vision blurred—Lisinopril—systemic scleroderma	0.00318	0.00318	CcSEcCtD
Mepivacaine—Anxiety—Mycophenolic acid—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Mepivacaine—Asthenia—Mometasone—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Mepivacaine—Hypotension—Azathioprine—systemic scleroderma	0.00317	0.00317	CcSEcCtD
Mepivacaine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Mepivacaine—Cardiac arrest—Prednisone—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Mepivacaine—Tremor—Lisinopril—systemic scleroderma	0.00316	0.00316	CcSEcCtD
Mepivacaine—Pruritus—Mometasone—systemic scleroderma	0.00313	0.00313	CcSEcCtD
Mepivacaine—Tachycardia—Leflunomide—systemic scleroderma	0.00312	0.00312	CcSEcCtD
Mepivacaine—Hyperhidrosis—Leflunomide—systemic scleroderma	0.00309	0.00309	CcSEcCtD
Mepivacaine—Angioedema—Lisinopril—systemic scleroderma	0.00308	0.00308	CcSEcCtD
Mepivacaine—Body temperature increased—Captopril—systemic scleroderma	0.00307	0.00307	CcSEcCtD
Mepivacaine—Oedema—Mycophenolic acid—systemic scleroderma	0.00305	0.00305	CcSEcCtD
Mepivacaine—Nausea—Pentoxifylline—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Mepivacaine—Chills—Mycophenolate mofetil—systemic scleroderma	0.00304	0.00304	CcSEcCtD
Mepivacaine—Syncope—Lisinopril—systemic scleroderma	0.00302	0.00302	CcSEcCtD
Mepivacaine—Shock—Mycophenolic acid—systemic scleroderma	0.003	0.003	CcSEcCtD
Mepivacaine—Hypotension—Leflunomide—systemic scleroderma	0.00299	0.00299	CcSEcCtD
Mepivacaine—Tachycardia—Mycophenolic acid—systemic scleroderma	0.00298	0.00298	CcSEcCtD
Mepivacaine—Loss of consciousness—Lisinopril—systemic scleroderma	0.00296	0.00296	CcSEcCtD
Mepivacaine—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.00295	0.00295	CcSEcCtD
Mepivacaine—Tension—Mycophenolate mofetil—systemic scleroderma	0.0029	0.0029	CcSEcCtD
Mepivacaine—Paraesthesia—Leflunomide—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Mepivacaine—Anaphylactoid reaction—Methotrexate—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Mepivacaine—Nervousness—Mycophenolate mofetil—systemic scleroderma	0.00287	0.00287	CcSEcCtD
Mepivacaine—Anxiety—Lisinopril—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Mepivacaine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00286	0.00286	CcSEcCtD
Mepivacaine—Hypotension—Mycophenolic acid—systemic scleroderma	0.00285	0.00285	CcSEcCtD
Mepivacaine—Vomiting—Mometasone—systemic scleroderma	0.00281	0.00281	CcSEcCtD
Mepivacaine—Sweating increased—Prednisone—systemic scleroderma	0.0028	0.0028	CcSEcCtD
Mepivacaine—Asthenia—Captopril—systemic scleroderma	0.00279	0.00279	CcSEcCtD
Mepivacaine—Headache—Mometasone—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Mepivacaine—Tremor—Mycophenolate mofetil—systemic scleroderma	0.00277	0.00277	CcSEcCtD
Mepivacaine—Oedema—Lisinopril—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Mepivacaine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Mepivacaine—Pruritus—Captopril—systemic scleroderma	0.00275	0.00275	CcSEcCtD
Mepivacaine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.00274	0.00274	CcSEcCtD
Mepivacaine—Somnolence—Mycophenolic acid—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Mepivacaine—Agitation—Mycophenolate mofetil—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Mepivacaine—Shock—Lisinopril—systemic scleroderma	0.00271	0.00271	CcSEcCtD
Mepivacaine—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.0027	0.0027	CcSEcCtD
Mepivacaine—Tachycardia—Lisinopril—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Mepivacaine—Body temperature increased—Azathioprine—systemic scleroderma	0.00268	0.00268	CcSEcCtD
Mepivacaine—Hyperhidrosis—Lisinopril—systemic scleroderma	0.00266	0.00266	CcSEcCtD
Mepivacaine—Syncope—Mycophenolate mofetil—systemic scleroderma	0.00265	0.00265	CcSEcCtD
Mepivacaine—Nausea—Mometasone—systemic scleroderma	0.00263	0.00263	CcSEcCtD
Mepivacaine—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.00259	0.00259	CcSEcCtD
Mepivacaine—Hypotension—Lisinopril—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Mepivacaine—Dizziness—Captopril—systemic scleroderma	0.00257	0.00257	CcSEcCtD
Mepivacaine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.00256	0.00256	CcSEcCtD
Mepivacaine—Hypertension—Mycophenolate mofetil—systemic scleroderma	0.00255	0.00255	CcSEcCtD
Mepivacaine—Urticaria—Leflunomide—systemic scleroderma	0.00254	0.00254	CcSEcCtD
Mepivacaine—Body temperature increased—Leflunomide—systemic scleroderma	0.00253	0.00253	CcSEcCtD
Mepivacaine—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Mepivacaine—Hypersensitivity—Azathioprine—systemic scleroderma	0.0025	0.0025	CcSEcCtD
Mepivacaine—Paraesthesia—Lisinopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Mepivacaine—Vomiting—Captopril—systemic scleroderma	0.00247	0.00247	CcSEcCtD
Mepivacaine—Somnolence—Lisinopril—systemic scleroderma	0.00244	0.00244	CcSEcCtD
Mepivacaine—Headache—Captopril—systemic scleroderma	0.00243	0.00243	CcSEcCtD
Mepivacaine—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Mepivacaine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Mepivacaine—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00241	0.00241	CcSEcCtD
Mepivacaine—Shock—Mycophenolate mofetil—systemic scleroderma	0.00237	0.00237	CcSEcCtD
Mepivacaine—Hypersensitivity—Leflunomide—systemic scleroderma	0.00236	0.00236	CcSEcCtD
Mepivacaine—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00235	0.00235	CcSEcCtD
Mepivacaine—Bradycardia—Prednisone—systemic scleroderma	0.00234	0.00234	CcSEcCtD
Mepivacaine—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.00233	0.00233	CcSEcCtD
Mepivacaine—Nausea—Captopril—systemic scleroderma	0.00231	0.00231	CcSEcCtD
Mepivacaine—Asthenia—Leflunomide—systemic scleroderma	0.0023	0.0023	CcSEcCtD
Mepivacaine—Pruritus—Leflunomide—systemic scleroderma	0.00226	0.00226	CcSEcCtD
Mepivacaine—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.00225	0.00225	CcSEcCtD
Mepivacaine—Dizziness—Azathioprine—systemic scleroderma	0.00224	0.00224	CcSEcCtD
Mepivacaine—Asthenia—Mycophenolic acid—systemic scleroderma	0.00219	0.00219	CcSEcCtD
Mepivacaine—Urticaria—Lisinopril—systemic scleroderma	0.00218	0.00218	CcSEcCtD
Mepivacaine—Body temperature increased—Lisinopril—systemic scleroderma	0.00217	0.00217	CcSEcCtD
Mepivacaine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Mepivacaine—Pruritus—Mycophenolic acid—systemic scleroderma	0.00216	0.00216	CcSEcCtD
Mepivacaine—Vomiting—Azathioprine—systemic scleroderma	0.00215	0.00215	CcSEcCtD
Mepivacaine—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Mepivacaine—Drowsiness—Methotrexate—systemic scleroderma	0.00214	0.00214	CcSEcCtD
Mepivacaine—Headache—Azathioprine—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Mepivacaine—Dizziness—Leflunomide—systemic scleroderma	0.00212	0.00212	CcSEcCtD
Mepivacaine—Sweating—Methotrexate—systemic scleroderma	0.00205	0.00205	CcSEcCtD
Mepivacaine—Vomiting—Leflunomide—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Mepivacaine—Hypersensitivity—Lisinopril—systemic scleroderma	0.00203	0.00203	CcSEcCtD
Mepivacaine—Dizziness—Mycophenolic acid—systemic scleroderma	0.00202	0.00202	CcSEcCtD
Mepivacaine—Nausea—Azathioprine—systemic scleroderma	0.00201	0.00201	CcSEcCtD
Mepivacaine—Headache—Leflunomide—systemic scleroderma	0.002	0.002	CcSEcCtD
Mepivacaine—Erythema—Prednisone—systemic scleroderma	0.002	0.002	CcSEcCtD
Mepivacaine—Asthenia—Lisinopril—systemic scleroderma	0.00197	0.00197	CcSEcCtD
Mepivacaine—Pruritus—Lisinopril—systemic scleroderma	0.00195	0.00195	CcSEcCtD
Mepivacaine—Vomiting—Mycophenolic acid—systemic scleroderma	0.00194	0.00194	CcSEcCtD
Mepivacaine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Mepivacaine—Headache—Mycophenolic acid—systemic scleroderma	0.00191	0.00191	CcSEcCtD
Mepivacaine—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Mepivacaine—Nausea—Leflunomide—systemic scleroderma	0.0019	0.0019	CcSEcCtD
Mepivacaine—Vision blurred—Prednisone—systemic scleroderma	0.00189	0.00189	CcSEcCtD
Mepivacaine—Agitation—Prednisone—systemic scleroderma	0.00184	0.00184	CcSEcCtD
Mepivacaine—Angioedema—Prednisone—systemic scleroderma	0.00183	0.00183	CcSEcCtD
Mepivacaine—Dizziness—Lisinopril—systemic scleroderma	0.00182	0.00182	CcSEcCtD
Mepivacaine—Nausea—Mycophenolic acid—systemic scleroderma	0.00181	0.00181	CcSEcCtD
Mepivacaine—Syncope—Prednisone—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Mepivacaine—Tinnitus—Methotrexate—systemic scleroderma	0.00179	0.00179	CcSEcCtD
Mepivacaine—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.00177	0.00177	CcSEcCtD
Mepivacaine—Loss of consciousness—Prednisone—systemic scleroderma	0.00176	0.00176	CcSEcCtD
Mepivacaine—Vomiting—Lisinopril—systemic scleroderma	0.00175	0.00175	CcSEcCtD
Mepivacaine—Convulsion—Prednisone—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Mepivacaine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Mepivacaine—Hypertension—Prednisone—systemic scleroderma	0.00173	0.00173	CcSEcCtD
Mepivacaine—Chills—Methotrexate—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Mepivacaine—Headache—Lisinopril—systemic scleroderma	0.00172	0.00172	CcSEcCtD
Mepivacaine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Mepivacaine—Anxiety—Prednisone—systemic scleroderma	0.0017	0.0017	CcSEcCtD
Mepivacaine—Erythema—Methotrexate—systemic scleroderma	0.00167	0.00167	CcSEcCtD
Mepivacaine—Nausea—Lisinopril—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Mepivacaine—Oedema—Prednisone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Mepivacaine—Anaphylactic shock—Prednisone—systemic scleroderma	0.00163	0.00163	CcSEcCtD
Mepivacaine—Back pain—Methotrexate—systemic scleroderma	0.00162	0.00162	CcSEcCtD
Mepivacaine—Shock—Prednisone—systemic scleroderma	0.00161	0.00161	CcSEcCtD
Mepivacaine—Tachycardia—Prednisone—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Mepivacaine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.00159	0.00159	CcSEcCtD
Mepivacaine—Hyperhidrosis—Prednisone—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Mepivacaine—Vision blurred—Methotrexate—systemic scleroderma	0.00158	0.00158	CcSEcCtD
Mepivacaine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.00153	0.00153	CcSEcCtD
Mepivacaine—Headache—Mycophenolate mofetil—systemic scleroderma	0.00151	0.00151	CcSEcCtD
Mepivacaine—Paraesthesia—Prednisone—systemic scleroderma	0.00147	0.00147	CcSEcCtD
Mepivacaine—Convulsion—Methotrexate—systemic scleroderma	0.00145	0.00145	CcSEcCtD
Mepivacaine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.00143	0.00143	CcSEcCtD
Mepivacaine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.00136	0.00136	CcSEcCtD
Mepivacaine—Hyperhidrosis—Methotrexate—systemic scleroderma	0.00132	0.00132	CcSEcCtD
Mepivacaine—Urticaria—Prednisone—systemic scleroderma	0.0013	0.0013	CcSEcCtD
Mepivacaine—Body temperature increased—Prednisone—systemic scleroderma	0.00129	0.00129	CcSEcCtD
Mepivacaine—Hypotension—Methotrexate—systemic scleroderma	0.00128	0.00128	CcSEcCtD
Mepivacaine—Paraesthesia—Methotrexate—systemic scleroderma	0.00123	0.00123	CcSEcCtD
Mepivacaine—Somnolence—Methotrexate—systemic scleroderma	0.00121	0.00121	CcSEcCtD
Mepivacaine—Hypersensitivity—Prednisone—systemic scleroderma	0.0012	0.0012	CcSEcCtD
Mepivacaine—Asthenia—Prednisone—systemic scleroderma	0.00117	0.00117	CcSEcCtD
Mepivacaine—Pruritus—Prednisone—systemic scleroderma	0.00116	0.00116	CcSEcCtD
Mepivacaine—Urticaria—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Mepivacaine—Dizziness—Prednisone—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Mepivacaine—Body temperature increased—Methotrexate—systemic scleroderma	0.00108	0.00108	CcSEcCtD
Mepivacaine—Vomiting—Prednisone—systemic scleroderma	0.00104	0.00104	CcSEcCtD
Mepivacaine—Headache—Prednisone—systemic scleroderma	0.00102	0.00102	CcSEcCtD
Mepivacaine—Hypersensitivity—Methotrexate—systemic scleroderma	0.00101	0.00101	CcSEcCtD
Mepivacaine—Asthenia—Methotrexate—systemic scleroderma	0.000979	0.000979	CcSEcCtD
Mepivacaine—Nausea—Prednisone—systemic scleroderma	0.00097	0.00097	CcSEcCtD
Mepivacaine—Pruritus—Methotrexate—systemic scleroderma	0.000966	0.000966	CcSEcCtD
Mepivacaine—Dizziness—Methotrexate—systemic scleroderma	0.000902	0.000902	CcSEcCtD
Mepivacaine—Vomiting—Methotrexate—systemic scleroderma	0.000868	0.000868	CcSEcCtD
Mepivacaine—Headache—Methotrexate—systemic scleroderma	0.000855	0.000855	CcSEcCtD
Mepivacaine—Nausea—Methotrexate—systemic scleroderma	0.000811	0.000811	CcSEcCtD
